A retrospective observational study on the efficacy and safety of pegylated recombinant human granulocyte-colony stimulating factor and recombinant human granulocyte-colony stimulating factor in patients with lymphoma.

Li-Hong Liu,Li-Li Wu,Chen Huang,Gui-Min Zhao,Guangyu Ma,Gao Ya,Lanping Diao,Yingzhen Yao,Xiaolin Wu,Zhe Gao

A retrospective observational study on the efficacy and safety of pegylated recombinant human granulocyte-colony stimulating factor and recombinant human granulocyte-colony stimulating factor in patients with lymphoma.

2020

Li-Hong Liu
Li-Li Wu
Chen Huang
Gui-Min Zhao
Guangyu Ma
Gao Ya
Lanping Diao
Yingzhen Yao
Xiaolin Wu
Zhe Gao

e20066Background: To evaluate the efficacy and safety of pegylated recombinant human granulocyte-colony stimulating factor (PEG-rhG-CSF) and recombinant human granulocyte-colony stimulating factor ...

Keywords:

Oncology
in patient
Recombinant DNA
Internal medicine
Granulocyte colony-stimulating factor
Retrospective cohort study
Lymphoma
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations